Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.22 +0.47 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Property, Plant & Equipment (Net) (2013 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) posted Property, Plant & Equipment (Net) of $235 million for Q2 2026, down 8.1% from $255.76 million a year earlier and down 1.7% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

At the end of FY2025, Ultragenyx Pharmaceutical's Property, Plant & Equipment (Net) came in at $244 million, down 8.3% from FY2024.

  • Annual Property, Plant & Equipment (Net) shows a five-year compound annual growth rate of 27.1% (FY2020 to FY2025).
  • In prior years, Ultragenyx Pharmaceutical's Property, Plant & Equipment (Net) was $266 million in FY2024 (-8.5%), $290.57 million in FY2023 (+11.9%), $259.73 million in FY2022 (+83.9%) and $141.25 million in FY2021 (+92.1%).
  • The Q2 2026 figure stands as the lowest quarterly Property, Plant & Equipment (Net) since Q3 2022.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined in each of the last nine quarters, with an average decline of 8.3% over the last eight quarters.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was Q3 2021, with growth of 144.1%; the weakest was Q1 2025, with a decline of 8.5%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $239 million (Q1 2026), $244 million (Q4 2025) and $249.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Ultragenyx Pharmaceutical 1.50 Bn -302.56 Mn 180.00 Mn 235.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 235.00 Mn
Mar 31, 2026 239.00 Mn
Dec 31, 2025 244.00 Mn
Sep 30, 2025 249.96 Mn
Jun 30, 2025 255.76 Mn
Mar 31, 2025 260.91 Mn
Dec 31, 2024 266.00 Mn
Sep 30, 2024 272.45 Mn
Jun 30, 2024 278.71 Mn
Mar 31, 2024 285.11 Mn
Dec 31, 2023 290.57 Mn
Sep 30, 2023 296.81 Mn
Jun 30, 2023 288.99 Mn
Mar 31, 2023 277.87 Mn
Dec 31, 2022 259.73 Mn
Sep 30, 2022 234.61 Mn
Jun 30, 2022 207.38 Mn
Mar 31, 2022 177.07 Mn
Dec 31, 2021 141.25 Mn
Sep 30, 2021 119.07 Mn
API Access

Ultragenyx Pharmaceutical Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=RARE&period=max&api_key=YOUR_API_KEY